Trial Profile
A multi-centre safety registry for malaria patients treated with EurartesimTM
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary)
- Indications Malaria
- Focus Adverse reactions
- 11 Mar 2014 New trial record